blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3430013

EP3430013 - CARBAPENEM COMPOUNDS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.09.2024
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  13.10.2023
FormerGrant of patent is intended
Status updated on  21.05.2023
FormerExamination is in progress
Status updated on  28.04.2023
FormerGrant of patent is intended
Status updated on  18.12.2022
FormerExamination is in progress
Status updated on  11.09.2020
FormerRequest for examination was made
Status updated on  21.12.2018
FormerThe international publication has been made
Status updated on  22.09.2017
Formerunknown
Status updated on  26.05.2017
Most recent event   Tooltip19.09.2024No opposition filed within time limitpublished on 23.10.2024 [2024/43]
Applicant(s)For all designated states
Orchid Pharma Limited
Orchid Towers 313 Valluvar Kottam High Road
Nungambakkam Chennai 600 034 TN / IN
For all designated states
Merck Sharp & Dohme LLC
126 East Lincoln Avenue
Rahway, New Jersey 07065 / US
[2023/45]
Former [2019/04]For all designated states
Orchid Pharma Limited
Orchid Towers 313 Valluvar Kottam High Road
Nungambakkam Chennai 600 034 TN / IN
For all designated states
Merck Sharp & Dohme Corp.
126 East Lincoln Avenue
Rahway, NJ 07065 / US
Inventor(s)01 / BALASUBRAMANIAN, Gopalan
Orchid Pharma Ltd
476/14 Old Mahabalipuram Road
Sozhanganallur
Chennai-600119 Tamilnadu / IN
02 / PAUL-SATYASEELA, Maneesh
410 Hara Vijaya Heights BWSSB
Pipeline Road
Uttarahalli Manevarthekaval
Banashankari 6th Stage
Bengaluru 560062 Karnataka / IN
03 / SRINIVASAN, Chidambaram, Venkateswaran
Orchid Pharma Ltd
476/14 Old Mahabalipuram Road
Sozhanganallur Chennai-600119 Tamilnadu / IN
04 / IYER, Sridhar, Ramanathan
504 Parsn Aahana
Mambakkam Road
Vengaivasal
Sithalapakkam Post
Chennai 600126 / IN
05 / PERIASAMY, Hariharan
Orchid Pharma Ltd
476/14 Old Mahabalipuram Road
Sozhanganallur
Chennai-600119 Tamilnadu / IN
06 / PARAMESWARAN, Venkatesan
Orchid Pharma Ltd
476/14 Old Mahabalipuram Road
Sozhanganallur
Chennai-600119 Tamilnadu / IN
07 / THIRUNAVUKKARASU, Bharani
Orchid Pharma Ltd
476/14 Old Mahabalipuram Road
Sozhanganallur
Chennai-600119 Tamilnadu / IN
08 / GUNTURU, Prabhakar, Rao
Gowrigudem (VIII)
Sidharam (PO)
Khammam (Dt)
Telangana - 507303 / IN
09 / DESHKUMAR, Manjula, Devi
Orchid Pharma Ltd
476/14 Old Mahabalipuram Road
Sozhanganallur
Chennai-600119 Tamilnadu / IN
10 / JAKKALA, Venkateshwarlu
Orchid Pharma Ltd
476/14 Old Mahabalipuram Road
Sozhanganallur
Chennai-600119 Tamilnadu / IN
11 / NARGUND, Ravi, P.
c/o Merck Sharp&Dohme Corp.
2000 Galloping Hill Road
Kenilworth NJ 07033 / US
12 / MILLER, Michael
1862 Lamberts Mill Road
Scotch Plains NJ 07076 / US
13 / SINGH, Sheo
19 Firethorn Drive
Edison NJ 08820 / US
14 / DONG, Shuzhi
c/o Merck Sharp&Dohme Corp.
2000 Galloping Hill Road
Kenilworth NJ 07033 / US
15 / WANG, Hongwu
c/o Merck Sharp&Dohme Corp.
2000 Galloping Hill Road
Kenilworth NJ 07033 / US
16 / YOUNG, Katherine
c/o Merck Sharp&Dohme Corp.
2000 Galloping Hill Road
Kenilworth NJ 07033 / US
 [2019/04]
Representative(s)HGF
HGF Limited
1 City Walk
Leeds LS11 9DX / GB
[2023/46]
Former [2019/04]HGF Limited
1 City Walk
Leeds LS11 9DX / GB
Application number, filing date17724297.115.03.2017
[2019/04]
WO2017IN00060
Priority number, dateIN20164100912716.03.2016         Original published format: IN201641009127
[2019/04]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2017158616
Date:21.09.2017
Language:EN
[2017/38]
Type: A1 Application with search report 
No.:EP3430013
Date:23.01.2019
Language:EN
The application published by WIPO in one of the EPO official languages on 21.09.2017 takes the place of the publication of the European patent application.
[2019/04]
Type: B1 Patent specification 
No.:EP3430013
Date:15.11.2023
Language:EN
[2023/46]
Search report(s)International search report - published on:EP21.09.2017
ClassificationIPC:C07D487/04, C07D519/00, A61K31/407, A61P31/00
[2019/04]
CPC:
C07D487/04 (EP,IL,KR,US); A61K31/407 (IL,KR); A61P31/00 (EP,KR);
A61P31/04 (EP,IL); C07D519/00 (EP,KR,US); Y02A50/30 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/04]
Extension statesBA14.09.2018
ME14.09.2018
Validation statesMA14.09.2018
MD14.09.2018
TitleGerman:CARBAPENEMVERBINDUNGEN[2019/04]
English:CARBAPENEM COMPOUNDS[2019/04]
French:COMPOSES DE CARBAPENEM[2023/01]
Former [2019/04]COMPOSÉS DE CARBAPÉNÈME
Entry into regional phase14.09.2018National basic fee paid 
14.09.2018Designation fee(s) paid 
14.09.2018Examination fee paid 
Examination procedure14.09.2018Examination requested  [2019/04]
14.09.2018Date on which the examining division has become responsible
01.05.2019Amendment by applicant (claims and/or description)
11.09.2020Despatch of a communication from the examining division (Time limit: M04)
18.12.2020Reply to a communication from the examining division
20.01.2022Despatch of a communication from the examining division (Time limit: M04)
27.01.2022Reply to a communication from the examining division
19.12.2022Communication of intention to grant the patent
27.04.2023Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
22.05.2023Communication of intention to grant the patent
29.09.2023Fee for grant paid
29.09.2023Fee for publishing/printing paid
29.09.2023Receipt of the translation of the claim(s)
Opposition(s)19.08.2024No opposition filed within time limit [2024/43]
Fees paidRenewal fee
13.03.2019Renewal fee patent year 03
12.03.2020Renewal fee patent year 04
12.03.2021Renewal fee patent year 05
14.02.2022Renewal fee patent year 06
14.02.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT15.11.2023
CZ15.11.2023
DK15.11.2023
EE15.11.2023
ES15.11.2023
HR15.11.2023
IT15.11.2023
LT15.11.2023
LV15.11.2023
NL15.11.2023
PL15.11.2023
RO15.11.2023
RS15.11.2023
SE15.11.2023
SK15.11.2023
SM15.11.2023
BG15.02.2024
NO15.02.2024
GR16.02.2024
IS15.03.2024
PT15.03.2024
[2024/36]
Former [2024/35]AT15.11.2023
CZ15.11.2023
DK15.11.2023
EE15.11.2023
ES15.11.2023
HR15.11.2023
LT15.11.2023
LV15.11.2023
NL15.11.2023
PL15.11.2023
RO15.11.2023
RS15.11.2023
SE15.11.2023
SM15.11.2023
BG15.02.2024
NO15.02.2024
GR16.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/34]AT15.11.2023
DK15.11.2023
EE15.11.2023
ES15.11.2023
HR15.11.2023
LT15.11.2023
LV15.11.2023
NL15.11.2023
PL15.11.2023
RS15.11.2023
SE15.11.2023
SM15.11.2023
BG15.02.2024
NO15.02.2024
GR16.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/33]AT15.11.2023
DK15.11.2023
ES15.11.2023
HR15.11.2023
LT15.11.2023
LV15.11.2023
NL15.11.2023
PL15.11.2023
RS15.11.2023
SE15.11.2023
SM15.11.2023
BG15.02.2024
NO15.02.2024
GR16.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/26]AT15.11.2023
ES15.11.2023
HR15.11.2023
LT15.11.2023
LV15.11.2023
NL15.11.2023
PL15.11.2023
RS15.11.2023
SE15.11.2023
BG15.02.2024
NO15.02.2024
GR16.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/25]AT15.11.2023
ES15.11.2023
HR15.11.2023
LT15.11.2023
NL15.11.2023
PL15.11.2023
RS15.11.2023
SE15.11.2023
BG15.02.2024
NO15.02.2024
GR16.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/24]AT15.11.2023
ES15.11.2023
HR15.11.2023
LT15.11.2023
NL15.11.2023
RS15.11.2023
SE15.11.2023
BG15.02.2024
NO15.02.2024
GR16.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/23]AT15.11.2023
ES15.11.2023
LT15.11.2023
NL15.11.2023
BG15.02.2024
GR16.02.2024
IS15.03.2024
PT15.03.2024
Former [2024/21]LT15.11.2023
NL15.11.2023
BG15.02.2024
GR16.02.2024
IS15.03.2024
Former [2024/20]GR16.02.2024
IS15.03.2024
Cited inInternational search[X]EP0372582  (BRISTOL MYERS SQUIBB CO [US])
by applicantUS4194047
 EP0126587
 EP0579826
 EP0528678
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.